PR Newswire

SIR-Spheres® Y-90 Resin Microspheres Recommended in New European Society of Medical Oncology (ESMO) Clinical Guidelines for Treating Metastatic Colorectal Cancer (mCRC)

Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer (mCRC) endorse radioembolisation, specifically with Yttrium-90 resin ...
Healio

Sirtex reports surge in sales of SIR-Spheres for liver tumors

Sirtex Medical Inc. announced its dose sales for SIR-Spheres Y-90 resin microspheres have increased by 21.2% in the U.S. for the second quarter of 2015 compared to the second quarter of 2014, ...
Finanznachrichten

SIR-Spheres Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows

SIR-Spheres Y-90 resin microspheres are approved for use in Argentina, Australia, Brazil, the European Union (CE Mark), Switzerland, Turkey, and several countries in Asia for the treatment of ...
Pharmabiz

Sirtex Medical completes enrollment in US RESiN registry to treat SIR-Spheres Y-90 resin microspheres

Sirtex Medical US Holdings, Inc. (Sirtex), a leading manufacturer of targeted liver cancer therapies, announced that enrollment in the US RESiN Registry has reached a milestone of 1,650 patients and ...